[Estimating doses of anti-cancer agents in sensitivity tests in vitro].
Kobayashi
K
K
Department of Respiratory Disease, Nippon Medical School, Tokyo, Japan.
Takemoto
T
T
Hino
M
M
Hayashihara
K
K
Nakahiro
K
K
Wasai
S
S
Niitani
H
H
D000230:Adenocarcinoma / Q000473:pathology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D016190:Carboplatin / Q000494:pharmacology; D002945:Cisplatin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D004354:Drug Screening Assays, Antitumor / Q000379:methods*; D006801:Humans; D016685:Mitomycin / Q000494:pharmacology; D013778:Tetrazolium Salts; D013844:Thiazoles; D014410:Tumor Stem Cell Assay
D000970:Antineoplastic Agents; D013778:Tetrazolium Salts; D013844:Thiazoles; D016685:Mitomycin; D004317:Doxorubicin; D016190:Carboplatin; C022616:thiazolyl blue; D002945:Cisplatin